The Research Antibodies Market is estimated to be valued at US$ 3,574.6 Mn in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The research antibodies market involves the production and usage of antibodies for biological research purposes. These antibodies are used to detect target proteins and other molecules in various research applications such as immunohistochemistry, flow cytometry, western blotting, and enzyme-linked immunosorbent assay (ELISA). The market offers a wide range of research antibodies for multiple research fields, including oncology, immunology, neuroscience, and stem cells.
Key Takeaways:
The global research antibodies market is expected to witness high growth, exhibiting a CAGR of 5.9% over the forecast period, due to increasing demand for personalized medicine and targeted therapeutics. The North American region is anticipated to dominate the market, driven by the presence of key players, sophisticated healthcare infrastructure, and significant investments in research and development. Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, and Cell Signalling Technology Inc. are some of the key players operating in the research antibodies market.
Read More:
